Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 1, 2017
Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorderNatalia Rodriguez, Astrid Morer, E Azucena González-Navarro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 12, 2025
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamineAlbert Martínez-Pinteño, David Olivares-Berjaga, Natalia Rodríguez, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 29, 2014
The effect of age on DNA concentration from whole saliva: implications for the standard isolation methodPatricia Gassó, Mireia Pagerols, Itziar Flamarique, et al.
Pharmacogenomics|December 17, 2013
Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trialPatricia Gassó, Sergi Mas, Katerina Papagianni, et al.
Psychiatry Research|December 17, 2018
Genetic variability in the serotoninergic system and age of onset in anorexia nervosa and obsessive-compulsive disorderMaria Teresa Plana, Teresa Torres, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2016
Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Ana Blázquez, et al.
Journal of Psychiatry & Neuroscience : JPN|April 13, 2016
Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophreniaBorja García-Bueno, Patricia Gassó, Karina S MacDowell, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Journal of Psychiatric Research|May 15, 2020
The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice modelAlbert Martínez-Pinteño, Susana García-Cerro, Sergi Mas, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 1, 2017
Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorderNatalia Rodriguez, Astrid Morer, E Azucena González-Navarro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 12, 2025
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamineAlbert Martínez-Pinteño, David Olivares-Berjaga, Natalia Rodríguez, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 29, 2014
The effect of age on DNA concentration from whole saliva: implications for the standard isolation methodPatricia Gassó, Mireia Pagerols, Itziar Flamarique, et al.
Pharmacogenomics|December 17, 2013
Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trialPatricia Gassó, Sergi Mas, Katerina Papagianni, et al.
Psychiatry Research|December 17, 2018
Genetic variability in the serotoninergic system and age of onset in anorexia nervosa and obsessive-compulsive disorderMaria Teresa Plana, Teresa Torres, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2016
Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Ana Blázquez, et al.
Journal of Psychiatry & Neuroscience : JPN|April 13, 2016
Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophreniaBorja García-Bueno, Patricia Gassó, Karina S MacDowell, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Journal of Psychiatric Research|May 15, 2020
The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice modelAlbert Martínez-Pinteño, Susana García-Cerro, Sergi Mas, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Pageof 11